View in EDS HTML Full Text PDF Full Text

The impact of the COVID-19 pandemic on medications for opioid use disorder services in the U.S. and Canada: a scoping review.

Saved in:
Bibliographic Details
Title: The impact of the COVID-19 pandemic on medications for opioid use disorder services in the U.S. and Canada: a scoping review.
Authors: Parker, Daniel G. (AUTHOR), Zentner, Daysi (AUTHOR), Burack, Jacob A. (AUTHOR), Wendt, Dennis C. (AUTHOR)
Source: Drugs: Education, Prevention & Policy. Dec2023, Vol. 30 Issue 6, p529-542. 14p.
Subjects: Substance abuse, Health services accessibility, Systematic reviews, Medical care, Research funding, Opioid analgesics, Thematic analysis, COVID-19 pandemic, Telemedicine
Geographic Terms: Canada, United States
Abstract: Since the arrival of the COVID-19 pandemic, preliminary evidence suggests that rates of opioid use and overdose in North America have only been exacerbated. During this time, healthcare services providing medications for opioid use disorder (MOUD) have faced heightened challenges, rapidly adjusting services in order to continue to provide access to treatment. To better understand the impact of the pandemic on MOUD services in the U.S. and Canada, this scoping review summarizes and synthesizes the existing literature on this topic. Articles were deemed eligible to be included in this review if they met the following three criteria: focused on MOUD services; situated within the COVID-19 pandemic; and situated within the U.S. or Canada. Common themes among the articles that met inclusion included the impacts of MOUD policy changes; the transition to telehealth; challenges to providing MOUD; innovative changes to services; and recommendations for policy and service changes. Many articles supported MOUD regulatory changes, with some finding these changes had increased access to MOUD for underserved populations. There is currently a pressing need to evaluate the impacts on MOUD services in greater depth, as recent changes could have lasting implications on future MOUD regulatory policies and treatment standards. [ABSTRACT FROM AUTHOR]
Copyright of Drugs: Education, Prevention & Policy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 173857806
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The impact of the COVID-19 pandemic on medications for opioid use disorder services in the U.S. and Canada: a scoping review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Parker%2C+Daniel+G%2E%22">Parker, Daniel G.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zentner%2C+Daysi%22">Zentner, Daysi</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burack%2C+Jacob+A%2E%22">Burack, Jacob A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wendt%2C+Dennis+C%2E%22">Wendt, Dennis C.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Drugs%3A+Education%2C+Prevention+%26+Policy%22">Drugs: Education, Prevention & Policy</searchLink>. Dec2023, Vol. 30 Issue 6, p529-542. 14p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Substance+abuse%22">Substance abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Health+services+accessibility%22">Health services accessibility</searchLink><br /><searchLink fieldCode="DE" term="%22Systematic+reviews%22">Systematic reviews</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+care%22">Medical care</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Opioid+analgesics%22">Opioid analgesics</searchLink><br /><searchLink fieldCode="DE" term="%22Thematic+analysis%22">Thematic analysis</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+pandemic%22">COVID-19 pandemic</searchLink><br /><searchLink fieldCode="DE" term="%22Telemedicine%22">Telemedicine</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Canada%22">Canada</searchLink><br /><searchLink fieldCode="DE" term="%22United+States%22">United States</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Since the arrival of the COVID-19 pandemic, preliminary evidence suggests that rates of opioid use and overdose in North America have only been exacerbated. During this time, healthcare services providing medications for opioid use disorder (MOUD) have faced heightened challenges, rapidly adjusting services in order to continue to provide access to treatment. To better understand the impact of the pandemic on MOUD services in the U.S. and Canada, this scoping review summarizes and synthesizes the existing literature on this topic. Articles were deemed eligible to be included in this review if they met the following three criteria: focused on MOUD services; situated within the COVID-19 pandemic; and situated within the U.S. or Canada. Common themes among the articles that met inclusion included the impacts of MOUD policy changes; the transition to telehealth; challenges to providing MOUD; innovative changes to services; and recommendations for policy and service changes. Many articles supported MOUD regulatory changes, with some finding these changes had increased access to MOUD for underserved populations. There is currently a pressing need to evaluate the impacts on MOUD services in greater depth, as recent changes could have lasting implications on future MOUD regulatory policies and treatment standards. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Drugs: Education, Prevention & Policy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=173857806
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09687637.2023.2181147
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 14
        StartPage: 529
    Subjects:
      – SubjectFull: Substance abuse
        Type: general
      – SubjectFull: Health services accessibility
        Type: general
      – SubjectFull: Systematic reviews
        Type: general
      – SubjectFull: Medical care
        Type: general
      – SubjectFull: Research funding
        Type: general
      – SubjectFull: Opioid analgesics
        Type: general
      – SubjectFull: Thematic analysis
        Type: general
      – SubjectFull: COVID-19 pandemic
        Type: general
      – SubjectFull: Telemedicine
        Type: general
      – SubjectFull: Canada
        Type: general
      – SubjectFull: United States
        Type: general
    Titles:
      – TitleFull: The impact of the COVID-19 pandemic on medications for opioid use disorder services in the U.S. and Canada: a scoping review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parker, Daniel G.
      – PersonEntity:
          Name:
            NameFull: Zentner, Daysi
      – PersonEntity:
          Name:
            NameFull: Burack, Jacob A.
      – PersonEntity:
          Name:
            NameFull: Wendt, Dennis C.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 09687637
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Drugs: Education, Prevention & Policy
              Type: main
ResultId 1